Special ArticleManagement of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
Under a Creative Commons license
open access
Key words
CAR T-cells
B-cell acute lymphoblastic leukemia (B ALL)
large B-cell lymphoma (LBCL)
multiple myeloma (MM)
cytokine release syndrome (CRS)
immune effector cell associated neurotoxicity syndrome (ICANS)
Cited by (0)
- †
These authors contributed equally to this work and should both be considered as first authors.
© 2021 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.